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Squaraine dyesThe synthesis of several aminosquaraine cationic dyes displaying strong absorption within the so-called
phototherapeutic window (650–850 nm) is described. Their cytotoxicity, under dark and illuminated
conditions, was tested against several human tumor cell lines (breast, lung, cervical and hepatocellular
carcinomas) and non-tumor porcine liver primary cells. All compounds showed to inhibit the growth
of the tumor cells upon irradiation more than in the absence of light, in more or less extension, clearly
exhibiting photodynamic activity. The photosensitizing ability against some cell lines, together with
the low toxicity for the non-tumor primary PLP2 cells displayed by some of the compounds synthetized,
turns them into potential candidates as photosensitizers for PDT.
 2017 Elsevier Ltd. All rights reserved.Introduction
Photodynamic therapy (PDT) is a promising minimally invasive
therapeutic technique that has been shown effective for cancer and
other non-oncological conditions [1]. It is based on the use of a sen-
sitizer that, after accumulating inside the abnormal cells, is excited
by light of an appropriate wavelength and interacts with oxygen,
leading to the production of reactive oxygen species (ROS) which
induce cell death via oxidative stress mechanisms. Amongst those,
singlet oxygen is generally considered to be the main cytotoxic
agent responsible for the photodynamic effect [2]. The prerequisite
of concurrence of this triad of components (photosensitizer, oxy-
gen and light), which individually are innocuous, for the photody-
namic process to take place turns PDT a particularly selective
modality, with unique advantages compared to conventional
tumor therapies such as surgery, chemotherapy and radiotherapy
[3,4].
Photofrin, a mixture of hematoporphyrin derivatives, was the
first photosensitizer to be approved by the regulatory agencies
and still the most extensively used for medical applications of
PDT [5]. This so-called first generation sensitizer presents however
several drawbacks, namely a lack of chemical homogeneity, pro-
longed coetaneous photosensitivity and a less than optimal light
absorption profile (k = 630 nm, e = 3200 M1 cm1) [6], whichentails the use of higher drug dosages, and limits the penetration
depth of light into tissue.
The crucial role of the photosensitizer in the success of PDT
turned the development of new sensitizers with better photophys-
ical and photobiological properties into an active area of research
in the two last decades and a lot of attention has been given to a
number of different classes of compounds as potential so-called
second generation sensitizers [5,7].
Squaraines, a class of functional dyes with sharp and intense
visible to NIR absorption which have found wide application in
the domain of photonics [8], have also attracted great interest as
a new class of potential photosensitizers for PDT [9] since, in
1997, Ramaiah et al. [10] synthesized and investigated the photo-
physical properties, including the singlet oxygen generation ability,
of some squaraines derived from phloroglucinol. As a result, a lot of
work has been published on the structural variation of squaraines
which, however, has been mainly focused on the variation of the
nature and substitution of the heterocyclic terminal groups [11].
The derivatization of the central squaric core, on the other hand,
has been poorly addressed and has been the focus of our research
for some years [12–14].
Notwithstanding a considerable number of squaraine com-
pounds has been designed and synthesized with the purpose of
PDT sensitizers, the in vitro assessment of their photodynamic
ability has been barely addressed [15–24]. The reports of in vivo
evaluation are even scarcer [17,18,21,25–27].
In this work we synthesized several squaraine dyes substituted
at the central four member ring with different amino groups and
Table 1
Visible spectral data for squaraine dyes 3 and 5a–e.
Dye R1 R2 kmaxa (nm) (log e)
3 – – 650 (5.24)b
5a H H 648 (5.41)
5b H CH2CH2OH 657 (4.67)
5c CH2CH2OH CH2CH2OH 667 (5.21)
5d H CH3 658 (5.23)b
5e CH3 CH2CH2OH 667 (5.19)
a Measured in MeOH/CH2Cl2 (99/1).
b From Ref.[12]
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against several human tumor cell lines (breast, lung, cervical and
hepatocellular carcinomas) and non-tumor porcine liver primary
cells. These aminosquaraine dyes are envisioned to present some
advantages over the common zwitterionic counterparts as their
cationic character may positively influence cellular uptake taking
advantage of the membrane potential, and the presence of amino
groups, besides red-shifting the dye’s absorption, may conve-
niently enhance solubility and interaction with the biological med-
ium. To the best of our knowledge this is the first report on the
in vitro photosensitizing ability of symmetrical aminosquaraine
dyes.
Aminosquaraines 5 were synthesized from the zwitterionic dye
3 by an expeditious methodology developed earlier by some of us
[12] (Scheme 1). The starting squaraine 3, easily prepared by the
condensation of two molar equivalents of 2-methylbenzothia-
zolium salt 2 with squaric acid, in refluxing n-butanol/pyridine,
was methylated with methyl triflate to furnish the crucial
O-methyl intermediate 4. The later then undergoes nucleophilic
substitution with appropriate amines to yield the triflate analogues
of 5. Each of the final compounds underwent counter-ion replace-
ment by iodine, by treatment of a methanolic solution of the com-
pound with excess 14% aqueous KI, in order to take benefit from
the so-called external heavy atom effect on the potential enhance-
ment of singlet oxygen generation [28].
All the synthesized dyes exhibit sharp and intense absorption
(e > 104 cm1 M1) in the red end of the visible spectrum, close
to the bottom end of the phototherapeutic window (Table 1). In
general, the amino-substituted dyes 5 display absorption at longer
wavelengths than the starting non-substituted analogue 3. The
chromophore shows typical donor–acceptor characteristics with
increasing bathochromic shift as the electron donating properties
of the auxochrome increases. The observed bathochromic shifts
ranged from 3 to 22 nm.
The cytotoxicity of the compounds synthesized was evaluated
against four human tumor cell lines: breast (MCF-7), non-small cell
lung (NCI-H460), cervical (HeLa) and hepatocellular (HepG2) carci-
nomas, and against a porcine liver primary cell culture (PLP2)Scheme 1. Synthesis of amiestablished by some of us, both in the absence of light and under
irradiation.
As a representative example, Fig. 1 shows the relative growth
inhibition ability of dyes 5a–e on the human tumor cell lines stud-
ied using 0,1 lM solutions of the dye, a concentration for which
growth inhibition in the absence of light was less than 20% in all
tests.
All compounds showed to inhibit the growth of the tumor cells
upon irradiation more than in the dark, in more or less extension,
clearly showing to display photocytotoxic effect. The more suscep-
tible cell lines to phototoxicity were HeLa and MCF-7, for which the
photodynamic treatment resulted in more significant differences
in the growth inhibition of the cells in the dark and upon irradia-
tion. Controls were set with the cells in the absence of the dyes
in 3% DMSO in DMEM and in the growth medium only. The cells
were independently submitted to the photodynamic treatment
and maintained in the dark. Neither DMSO alone, nor light alone,
nor the combination of both was found to induce toxicity on the cells.
Although the study of the exact nature of the photodynamic
action mechanism of the synthesized dyes is out of the scope of
this work, it is worthwhile to mention that the majority of the
compounds assayed have shown singlet oxygen generation ability
[14,29].
The GI50 values (compound concentration resulting in 50% of
growth inhibition) determined for squaraine dyes 5a–e are
presented in Table 2.nosquaraine dyes 5a–e.
Fig. 1. Growth inhibition of MCF-7, HeLa, HepG2 and NCI-H460 cell lines upon treatment with dyes 5a–e (0.1 lM) in the dark and after irradiation. Results are presented as
mean values ± standard deviation (SD).
Table 2
Cytotoxicity (GI50 values, mM) of compounds 5a–e (mean ± SD).
Compound Condition MCF-7 NCI-H460 HepG2 HeLa PLP2
5a Dark >10 >10 4.571 ± 0.379 >10 >10
Irradiated 0.918 ± 0.095 8.347 ± 0.363 0.665 ± 0.049 0.288 ± 0.017 4.981 ± 0.254
t-Students test p-value – – <0.001 – –
5b Dark 7.361 ± 0.764 8.820 ± 0.698 7.829 ± 0.694 >10 3.727 ± 0.579
Irradiated 0.224 ± 0.015 0.440 ± 0.024 0.110 ± 0.011 0.097 ± 0.001 0.385 ± 0.006
t-Students test p-value <0.001 <0.001 <0.001 – <0.001
5c Dark 5.337 ± 0.413 0.940 ± 0.085 4.493 ± 0.391 >10 0.621 ± 0.005
Irradiated 0.257 ± 0.026 0.404 ± 0.034 0.722 ± 0.077 0.088 ± 0.006 0.340 ± 0.017
t-Students test p-value <0.001 <0.001 <0.001 – <0.001
5d Dark 0.576 ± 0.043 0.507 ± 0.064 7.083 ± 0.767 2.223 ± 0.138 0.410 ± 0.050
Irradiated 0.054 ± 0.004 0.171 ± 0.023 0.078 ± 0.005 0.071 ± 0.009 0.126 ± 0.048
t-Students test p-value <0.001 <0.001 <0.001 <0.001 0.001
5e Dark 0.737 ± 0.039 0.767 ± 0.045 7.535 ± 0.818 2.636 ± 0.062 0.717 ± 0.115
Irradiated 0.239 ± 0.034 0.455 ± 0.012 0.271 ± 0.014 0.273 ± 0.007 0.471 ± 0.044
t-Students test p-value <0.001 <0.001 <0.001 <0.001 0.008
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range of tested concentrations, squaraine 5a only showed inhibi-
tory activity against the HepG2 cell line, and yet with a relatively
high GI50 value. The remaining compounds presented inhibitory
activity for all the cell lines tested, though in variable extension,
except dyes 5b and 5c which were inactive against the HeLa cell
line in the range of the concentrations used.
Upon irradiation the GI50 values decreased, in some cases very
appreciably, showing significant photodynamic effect of the dyes.
For compounds 5a–d, the lowest GI50 values were obtained consis-
tently against the HeLa cell line, while for dye 5e the lowest GI50
value was obtained against the MCF-7 cell line. The largestdifferences between the GI50 values obtained in the dark and upon
irradiation, which are very relevant in terms of the usefulness of
the photodynamic effect, were observed precisely for the HeLa cell
line, with dyes 5a–c, which were shown to be inactive against this
cell line in the dark, in the range of the concentrations used. The
HepG2 cell line turned out to be also very susceptible to the
photodynamic treatment using dyes 5b, 5d and 5e. Compound
5d presented the lowest GI50 value of all, whatever the tested cell
line; nevertheless, it was not the compound that presented the
highest differences between the dark and irradiated assays.
The evaluation of the cytotoxicity for PLP2 (non-tumor cells) is
very important since mammalian hepatocytes still represent a
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the production of various metabolites, which are the ultimate
cause of toxicity [30].
Apart from dye 5a which, in the range of the tested concentra-
tions, was inactive in the absence of light and presented a GI50
value of 4.981 ± 0.254 lM upon irradiation, all compounds showed
also some cytotoxicity against PLP2 cells. Nevertheless, the GI50
values obtained for the PLP2 cells were consistently higher, either
in the dark or under irradiation, than those obtained against the
tumor cell lines. It is worth mentioning that the locoregional nat-
ure of the photodynamic effect can diminish or even surmount
the importance of the cytotoxicity observed in the non-tumor cells.
In conclusion, the aminosquaraine dyes synthesized, displaying
strong absorption within the phototerapeutic window, have shown
to able to inhibit the growth of the human tumor cell lines tested
(MCF-7, NCI-H460, HeLa, and HepG2) upon irradiation more than
in the dark, in some cases very substantially, clearly showing to
display photocytotoxic activity.
The differences observed for some of the dyes between the GI50
values obtained in the absence of light and upon irradiation, turn
them into potential candidates as photosensitizers for PDT, in par-
ticular compound 5a which showed the lowest toxicity for the
non-tumor primary PLP2 cells.
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